Metoperil AT 50 Tablet contains Metoprolol Succinate 50mg + Amlodipine 5mg + Telmisartan 40mg, a combination medicine used for management of hypertension and cardiovascular risk reduction. It helps control blood pressure and supports overall heart health.
Metoprolol acts as a beta-blocker, reducing heart rate and cardiac workload, Amlodipine is a calcium channel blocker that relaxes blood vessels, and Telmisartan is an angiotensin receptor blocker that further reduces blood pressure. Together, they provide comprehensive cardiac protection.
This tablet is commonly prescribed for patients with moderate to severe hypertension or high cardiovascular risk, offering effective blood pressure control and improved compliance due to the combination formulation.
Metoperil AT 50 Tablet is valued for its triple-action mechanism, proven efficacy in cardiac management, and consistent clinical performance, making it a trusted option for hospitals, clinics, and cardiac care programs.